Source link : https://newshealth.biz/health-news/bispecific-trial-in-myeloma-sparks-talks-of-functional-cure/
(MedPage Today) — ORLANDO — Combining teclistamab (Tecvayli) with subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with relapsed/refractory… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118914 Author : Publish date : 2025-12-09 19:35:00 Copyright for syndicated content belongs to the linked Source.
The post Bispecific Trial in Myeloma Sparks Talks of ‘Functional Cure’ first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-09 19:35:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8